Literature DB >> 9850481

The public health burden of diabetes and the reality of limits.

F Vinicor1.   

Abstract

Improvements in diabetes surveillance, diagnosis, and treatment have, in recent years, heightened awareness of the burden of diabetes and aroused concern about the amount of health care resources that will be necessary to manage this disease effectively in the future. Examination of diabetes from the twin perspectives of economics and public health challenges basic notions of the health care tradition in the Western world: the real-world combination of finite resources and the growing need/demand for health services forces the consideration of limits in the provision of health care. The growing need to rationally allocate limited health care resources poses emotional, potentially divisive questions of science, politics, economics, and ethics that patients and physicians must each address.

Entities:  

Mesh:

Year:  1998        PMID: 9850481     DOI: 10.2337/diacare.21.3.c15

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  6 in total

Review 1.  Nut consumption and risk of cancer and type 2 diabetes: a systematic review and meta-analysis.

Authors:  Lang Wu; Zhen Wang; Jingjing Zhu; Angela L Murad; Larry J Prokop; Mohammad H Murad
Journal:  Nutr Rev       Date:  2015-07       Impact factor: 7.110

Review 2.  Pharmacologic Therapy of Diabetes and Overall Cancer Risk and Mortality: A Meta-Analysis of 265 Studies.

Authors:  Lang Wu; Jingjing Zhu; Larry J Prokop; Mohammad Hassan Murad
Journal:  Sci Rep       Date:  2015-06-15       Impact factor: 4.379

3.  Changes in quality of care and costs induced by implementation of a diabetes program in a social security entity of Argentina.

Authors:  Lorena González; Jorge F Elgart; Héctor Calvo; Juan J Gagliardino
Journal:  Clinicoecon Outcomes Res       Date:  2013-07-04

4.  Peer support to decrease diabetes-related distress in patients with type 2 diabetes mellitus: design of a randomised controlled trial.

Authors:  Lianne de Vries; Amber Awa van der Heijden; Esther van 't Riet; Caroline A Baan; Piet J Kostense; Mieke Rijken; Guy Ehm Rutten; Giel Nijpels
Journal:  BMC Endocr Disord       Date:  2014-03-04       Impact factor: 2.763

5.  A competing risk analysis of sequential complication development in Asian type 2 diabetes mellitus patients.

Authors:  Li-Jen Cheng; Jeng-Huei Chen; Ming-Yen Lin; Li-Chia Chen; Chun-Huan Lao; Hsing Luh; Shang-Jyh Hwang
Journal:  Sci Rep       Date:  2015-10-28       Impact factor: 4.379

6.  Alpha-glucosidase inhibitors and risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis.

Authors:  Yiming Zhao; Yongjian Wang; Hanyu Lou; Lizhen Shan
Journal:  Oncotarget       Date:  2017-04-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.